| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.19 | 3e-05 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.13 | 6e-05 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | -0.19 | 0.0003 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0004 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | -0.18 | 0.0004 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | -0.18 | 0.0006 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | -0.18 | 0.0006 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0009 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0009 |